期刊文献+

盐酸头孢卡品匹酯片治疗急性细菌性感染多中心双盲随机对照临床研究 被引量:5

Multicenter,double-blind,randomized controlled clinical trial of cefcapene pivoxil hydrochloride tablets in the treatment of acute bacterial infections
原文传递
导出
摘要 目的评价头孢卡品匹酯片(第3代头孢菌素类抗生素)治疗急性细菌性感染的临床疗效和安全性。方法用多中心双盲双模拟随机平行对照试验设计,选择急性呼吸系统和泌尿系统细菌感染患者,试验组口服头孢卡品匹酯片100 mg,每日3次;对照组口服头孢泊肟酯片200 mg,每日2次,疗程5~14天。结果试验组入组135例,疗效评价128例,安全性评价135例;对照组入组134例,疗效评价129例,安全性评价134例。治疗后,2组总有效率分别为97.66%,94.57%;总的细菌清除率分别为96.36%,94.06%;药物不良反应发生率,试验组为5.19%,对照组为4.48%,2组比较差异无统计学意义,未见严重不良反应。结论头孢卡品匹酯片治疗急性呼吸系统和泌尿系统细菌感染,临床疗效确切,安全性较好。 Objective To evaluate the clinical efficacy and safety of oral cefcapene pivoxil in the treatment of acute bacteria infections,including respiratory tract infection and urinary tract infection.Methods A multicenter double-blind randomized controlled clinical trial was conducted.Cefcapene pivoxil was 100 mg three times a daily by oral.Cefpodoxime proxetil as a controlled drug was 200 mg twice daily by oral.The course of treatment was 5-14 days.Results In the randomized controlled study,135 patients were enrolled in cefcapene group,135 patients were assessable for safety and 128 patients were assessable for efficacy.While 134 patients were enrolled in cefpodoxime group,134 patients were assessed safety and 129 patients assessed efficacy.The clinical total effective rate in cefcapene group was 97.66%;the bacterial clearance rate was 96.36%.While those of cefpodoxime group were 94.57% and 94.06%,respectively.The incidence of adverse reaction was 5.19% and 4.48%,respectively.There was not marked difference between the two groups in statistics.In trial and control groups no serious adverse reaction was reported.Conclusion Cefcapene pivoxil is effective and safe for the treatment of acute respiratory or urinary tract bacterial infections.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2012年第1期3-5,共3页 The Chinese Journal of Clinical Pharmacology
关键词 头孢卡品匹酯片 头孢泊肟酯片 急性细菌性感染 呼吸系统 泌尿系统 cefcapene tablets cefpodoxime acute bacterial infection respiratory tract infection urinary tract infection
  • 相关文献

参考文献1

共引文献8

同被引文献47

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部